A randomized prospective study of ceftazidime versus ceftazidime plus flucloxacillin in the empiric treatment of febrile episodes in severely neutropenic patients.
about
Empirical antibiotics targeting Gram-positive bacteria for the treatment of febrile neutropenic patients with cancerAdditional anti-Gram-positive antibiotic treatment for febrile neutropenic cancer patientsCost-effectiveness of ceftazidime or imipenem/cilastatin versus ceftriaxone + aminoglycoside in the treatment of febrile episodes in neutropenic cancer patients in Germany.Randomized prospective study of ceftazidime versus ceftazidime plus cephalothin in empiric treatment of febrile episodes in severely neutropenic patients.Evaluation of an immunofluorescent-antibody test for rapid identification of Pseudomonas aeruginosa in blood cultures.Empirical antibiotics targeting gram-positive bacteria for the treatment of febrile neutropenic patients with cancer.Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation: a prospective randomized trial.Empirical monotherapy with meropenem versus imipenem/cilastatin for febrile episodes in neutropenic patients.Empiric treatment of localized infections in the febrile neutropenic patient with monotherapy.Ceftazidime as initial therapy in febrile patients with acute leukemia during induction chemotherapy. Leukemia Group of Middle Sweden.Ceftazidime with or without amikacin for the empiric treatment of localized infections in febrile, granulocytopenic patients.A randomized prospective study of ceftazidime and ciprofloxacin with or without teicoplanin as an empiric antibiotic regimen for febrile neutropenic patients.Amikacin plus piperacillin versus ceftazidime as initial therapy in granulocytopenic patients with presumed bacteremia.A randomised comparison of ceftazidime and piperacillin, both in combination with flucloxacillin for treatment of febrile episodes in neutropenic children. Finnish Three-Centre Study.A randomised trial of empirical antibiotic therapy in febrile neutropenic patients with hematological disorders: ceftazidime versus azlocillin plus amikacin.Ceftazidime sodium carbonate versus ceftazidime arginine as empirical monotherapy in febrile neutropenic patients.Controversies in the antibacterial treatment of patients with neutropenia: a matter of comprehension or apprehension?
P2860
Q24201136-9BAFC7DD-5AC2-49B7-A0E0-80E4D54131ADQ24246468-D6AD85D7-DD8A-4E03-9C4C-3885B58F5536Q33535030-D5AE61F9-3758-4912-A51E-74963B9FDF99Q35536384-4DCB5C7A-756E-4613-8953-044B2F8E4BE2Q37150320-4A7F995A-A326-4898-AC1C-A79AA901BA0DQ38747206-6B33B1AE-EB3A-4DE3-9076-C526E0861DD0Q40489194-0E27E50B-0C43-4460-B7D6-92527FF0F2F2Q40661480-7FFEA035-D94D-4FAF-9AF8-DEDB93222BDDQ40721491-481A3E30-1F32-4A8B-B17F-3399D5327BAAQ40739131-D99E0180-5F0C-4145-A4D0-AD52B449C435Q40743909-AE080086-1FD4-4399-8E13-06D07D3AA542Q40755964-5E79BE71-E796-4371-9CA5-D7264A520298Q40766816-964CDCA0-B935-4B07-9EA5-EDCBE40C5E1BQ40767303-001821C6-E2ED-4BAC-9A6D-741900629B47Q40770561-1155512F-A4D5-4AD6-8046-B716A64D5B81Q40787432-BAB117CC-2BBA-4218-9406-D69A4D475A5BQ41348034-FF5CF887-3B43-4959-A46A-621E1101DF77
P2860
A randomized prospective study of ceftazidime versus ceftazidime plus flucloxacillin in the empiric treatment of febrile episodes in severely neutropenic patients.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
A randomized prospective study ...... severely neutropenic patients.
@ast
A randomized prospective study ...... severely neutropenic patients.
@en
type
label
A randomized prospective study ...... severely neutropenic patients.
@ast
A randomized prospective study ...... severely neutropenic patients.
@en
prefLabel
A randomized prospective study ...... severely neutropenic patients.
@ast
A randomized prospective study ...... severely neutropenic patients.
@en
P2093
P2860
P356
P1476
A randomized prospective study ...... severely neutropenic patients.
@en
P2093
Holdrinet R
Williams K
de Neeff J
de Witte T
P2860
P304
P356
10.1128/AAC.28.6.824
P407
P577
1985-12-01T00:00:00Z